Board of Directors
Mary Lynn Mathre, RN, MSN, CARN, CNLC
President & Substance Abuse Consultant
Founding Director
Howardsville, VA
This email address is being protected from spambots. You need JavaScript enabled to view it.
Al Byrne, Lcdr, SC, USN (ret).
Secretary-Treasurer
Son of Cancer Patient & Founding Director
Howardsville, VA
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sunil Aggarwal, MD, PhD
Medicinal Cannabis Expert
Director
New York, NY
This email address is being protected from spambots. You need JavaScript enabled to view it.
Michael Aldrich, PhD.
Director
Educator, Historian
San Francisco, CA
This email address is being protected from spambots. You need JavaScript enabled to view it.
In Memoriam:
Joe Barker, HIV Patient
Founding Director
Barbara Douglass
Founding Director
IND Patient, Multiple Sclerosis
Lakeside, IA
This email address is being protected from spambots. You need JavaScript enabled to view it.
George McMahon
Founding Director
IND Patient, Nail Patella Syndrome
Livermore, IA
This email address is being protected from spambots. You need JavaScript enabled to view it.
In Memoriam:
Corrine Millet, IND Patient, Glaucoma
Founding Director
Elvy Musikka
Director
IND Patient, Glaucoma
Eugene, OR
This email address is being protected from spambots. You need JavaScript enabled to view it.
In Memoriam:
Mae Nutt, “Grandma Marijuana”
Founding Director
Denis Petro, MD
Founding Director
Practicing Neurologist & Drug Researcher
Arlington, VA
This email address is being protected from spambots. You need JavaScript enabled to view it.
Irvin Rosenfeld
Director
IND Patient, Chronic Pain
Ft. Lauderdale, FL
This email address is being protected from spambots. You need JavaScript enabled to view it.
Juan Sanchez-Ramos, MD,PhD
Director
Academic Neurologist/Neuroscientist
Tampa, FL
This email address is being protected from spambots. You need JavaScript enabled to view it.
Ralph A. Smith, Esq.
Director
Cannabis Defense Attorney
Louisville, NE
This email address is being protected from spambots. You need JavaScript enabled to view it.
IND = Investigational New Drug (FDA program)